171 related articles for article (PubMed ID: 7907656)
1. Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: a study on the nature of stromal and giant cells, and their interrelations.
Hasegawa T; Hirose T; Seki K; Sano T; Hizawa K
J Pathol; 1993 Jul; 170(3):305-10. PubMed ID: 7907656
[TBL] [Abstract][Full Text] [Related]
2. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
Zheng MH; Fan Y; Smith A; Wysocki S; Papadimitriou JM; Wood DJ
J Cell Biochem; 1998 Jul; 70(1):121-9. PubMed ID: 9632113
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas.
Lukás Z; Dvorák K; Kroupová I; Valásková I; Habanec B
Pancreas; 2006 Apr; 32(3):325-9. PubMed ID: 16628090
[TBL] [Abstract][Full Text] [Related]
5. An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells.
Athanasou NA; Bliss E; Gatter KC; Heryet A; Woods CG; McGee JO
J Pathol; 1985 Nov; 147(3):153-8. PubMed ID: 4067733
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumors of bone. An immunohistochemical study.
Liu TC; Ji ZM; Wang LT
Pathol Res Pract; 1989 Oct; 185(4):448-53. PubMed ID: 2602217
[TBL] [Abstract][Full Text] [Related]
7. Lysozyme and alpha 1-antitrypsin in giant-cell tumor of bone and in other lesions that contain giant cells.
Ling L; Klein MJ; Sissons HA; Steiner GC
Arch Pathol Lab Med; 1986 Aug; 110(8):713-8. PubMed ID: 3524506
[TBL] [Abstract][Full Text] [Related]
8. Giant cell tumor of the ovary. Immunohistochemical evidence of origin from stromal ovarian cells.
Franco V; Florena AM; Orlando E; Becchina G
Histol Histopathol; 1995 Jan; 10(1):55-60. PubMed ID: 7756744
[TBL] [Abstract][Full Text] [Related]
9. Macrophages in giant cell tumours of bone.
Wood GW; Neff JR; Gollahon KA; Gourley WK
J Pathol; 1978 May; 125(1):53-8. PubMed ID: 722390
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumor of bone: a unique paradigm of stromal-hematopoietic cellular interactions.
Robinson D; Einhorn TA
J Cell Biochem; 1994 Jul; 55(3):300-3. PubMed ID: 7962160
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
13. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
Sathi GS; Nagatsuka H; Tamamura R; Fujii M; Gunduz M; Inoue M; Rivera RS; Nagai N
Histopathology; 2008 Oct; 53(4):458-67. PubMed ID: 18983611
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
15. Fibroma and giant cell tumor of tendon sheath: a comparative histological and immunohistological study.
Maluf HM; DeYoung BR; Swanson PE; Wick MR
Mod Pathol; 1995 Feb; 8(2):155-9. PubMed ID: 7777476
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical comparison of p53, Ki-67, CD68, vimentin, α-smooth muscle actin and alpha-1-antichymotry-psin in oral peripheral and central giant cell granuloma.
Kujan O; Al-Shawaf AZ; Azzeghaiby S; AlManadille A; Aziz K; Raheel SA
J Contemp Dent Pract; 2015 Jan; 16(1):20-4. PubMed ID: 25876945
[TBL] [Abstract][Full Text] [Related]
17. The expression of mRNA for insulin-like growth factors and their receptor in giant cell tumors of human bone.
Middleton J; Arnott N; Walsh S; Beresford J
Clin Orthop Relat Res; 1996 Jan; (322):224-31. PubMed ID: 8542699
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
[TBL] [Abstract][Full Text] [Related]
19. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
